Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors
Molecular Pharmaceutics · 01.06.2026 · 23 (6) · 3458-3467
DOI: 10.1021/acs.molpharmaceut.6c00244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.05.2026. Verfasst von Xingguo Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radio…. Hauptthemen laut MEDLINE: Zirconium, Radioisotopes, GPI-Linked Proteins, Neoplasms. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Youth Research Talent Training Program of Peking University Cancer Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department…
- School of Medicine, Xiamen University, Xiamen 361101, China.
- Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Ho…
- Institute of Biomedical Engineering, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.
Förderung
- Youth Research Talent Training Program of Peking University Cancer Hospital
Zitieren
APA
Hou, X., Yang, L., Liu, F., Wang, F., Liu, S., Yao, Y., Wang, Z., Qi, C., Zhu, H., & Yang, Z. (2026). Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors. Molecular Pharmaceutics, 23(6), 3458-3467. https://doi.org/10.1021/acs.molpharmaceut.6c00244
Vancouver
Hou X, Yang L, Liu F, Wang F, Liu S, Yao Y, et al. Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors. Molecular Pharmaceutics. 2026;23(6):3458-3467. doi:10.1021/acs.molpharmaceut.6c00244
BibTeX
@article{Hou2026,
author = {Hou, Xingguo and Yang, Lulin and Liu, Futao and Wang, Feng and Liu, Song and Yao, Yuan and Wang, Zilei and Qi, Changsong and Zhu, Hua and Yang, Zhi},
title = {Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {6},
pages = {3458--3467},
doi = {10.1021/acs.molpharmaceut.6c00244}
}
EUVIMED